ABSTRACT The transfer of lipoprotein-bound cholesterol into adrenal cells was examined. Adrenal glands from unstimulated or corticotropin stimulated hypophysectomized rats were incubated with high density lipoprotein (HDL) or low density lipoprotein LDL containing radiolabeled cholesterol. The rate of transfer of labeled cholesterol from HDL into the glands was two to three times greater than from LDL. Corticotropin stimulation increased the transfer of cholesterol from HDL but not LDL. The effects of corticotropin were not dependent on subsequent cholesterol utilization for steroidogenesis. The process of cholesterol transfer from HDL was linear with time over 2 hr at 370 and greatly reduced at 40. In addition, the transfer process became saturated above an HDL cholesterol concentration of 900 sg/ml. About 25% of the labeled adrenal cholesterol arising from HDL was recovered within the mitochondria. The labeled cholesterol within isolated mitochondria could undergo mitochondrial conversion to pregnenolone. Finally, the delipidated HDL apolipoproteins, apoA-I and apoA-II, when added to incubations containing less than saturating concentrations of HDL, stimulated transfer of labeled cholesterol from HDL to adrenal cells. These studies suggest that rat adrenal tissue possesses an HDL specific hormonally-responsive mechanism for accumulating extracellular cholesterol and that apoA-I and apoA-II have a significant function in the uptake process.
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The mechanisms responsible for transferring cholesterol from plasma into cells are of particular interest because of their possible role in atherosclerotic disease. Adrenal tissue may serve as a useful model for studying these mechanisms because studies in man (1, 2) and the rat (3, 4) showed that 80% or more of the cholesterol substrate for adrenal steroidogenesis may come from plasma. However, little is known about the process by which extracellular cholesterol enters the adrenal cells. Dexter et al. (4) have observed that the uptake process is stimulated by corticotropin (adrenocorticotrophic hormone, ACTH), and furthermore that the stimulatory effect of ACTH persists even when utilization of accumulating cholesterol is blocked by specific inhibitors.
Serum cholesterol is lipoprotein bound, predominantly by the high density lipoprotein (HDL) and low density lipoprotein (LDL) fractions. In the rat (5), 60% of the circulating cholesterol is found in HDL and 30% in LDL, while in man 30% and 60% are found in HDL and LDL, respectively (6) . In order to better understand the uptake of cholesterol by adrenal cells as well as ACTH regulation of the uptake process, we have examined the ability of HDL and LDL to serve as substrate for transfer of cholesterol to the adrenal. The observations reported here suggest that HDL is the preferred substrate for adrenal cholesterol uptake, and that uptake from HDL is regulated by ACTH. Furthermore, these studies suggest that the HDL apoproteins, apoA-I and apoA-II, play a role in the cholesterol uptake process. Table legends . Incubations were performed for up to 2 hr at 370 or 40 in an Eberbach shaker bath in a 95% 02-5% CO2 atmosphere. The incubation media for all experiments using quartered adrenal glands contained AG (0.25 mg/ml) to prevent conversion of cholesterol to pregnenolone (7) . At the completion of the incubation, medium was removed and the glands washed three times with 3-5 ml of standard buffer at 4°. The final wash contained less than 2% of the counts retained within the glands.
MATERIALS AND METHODS
Incubated washed glands were then homogenized in 2 ml of standard buffer and total protein, cholesterol, and radioactivity measured. Greater than 80% of the radioactivity associated with incubated glands could be sedimented by centrifugation at 100,000 X g for 1 hr. In initial experiments, the identity of the radiolabeled species accumulated in the incubated glands was determined by thin-layer chromatography of chloroform/methanol (3/1) tissue extracts performed as described below. About 95% of the extracted counts comigrated with the cholesterol standard while another 2-5% of the counts comigrated with cholesterol oleate. This indicates that the basic cholesterol structure remained intact throughout the experiment. In later experiments, extraction and chromatography were omitted.
Mitochondrial Incubation. Conversion of cholesterol to pregnenolone, the rate limiting step in adrenal steroidogenesis, occurs in the mitochondria (8) . It was therefore of interest to determine the amount of labeled cholestesterol within mitochondria from incubated adrenals and also to determine if it could be converted to pregnenolone. (10) . Measurements of total, free, and esterified cholesterol were performed as described by Sperry and Webb (11) .
Pregnenolone was extracted from mitochondrial homogenates by using dichloromethane as previously described (9 Pairs of adrenal glands from hypophysectomized ACTH treated and untreated rats were incubated for 30 min in standard media containing AG and labeled lipoproteins as described. The HDL and LDL cholesterol concentrations in the incubation media varied from 90 to 880 ug/ml and 290 to 770 ug/ml, respectively. The 14C activity in each case varied from 1 to 8 x 105 cpm/ml. To compare results among experiments employing varying amounts of label in the media, we expressed the number of counts contained within each pair of washed glands relative to each 1000 counts/ml of incubation media. The data shown are the means + standard deviation. The number of observations is shown in parentheses. Table 2 shows the results of these treatments on adrenal protein content, cholesterol content, and accumulation of labeled cholesterol. Both of the groups receiving ACTH showed an increase in adrenal protein content. The adrenals from the group receiving ACTH without AG were depleted of cholesterol. This reflects the stimulatory effect of ACTH on cholesterol utilization for steroidogenesis and suggests that under these circumstances, in vivo, the enhancement of ste- Characteristics of Adrenal Cholesterol Uptake from HDL. Further studies were performed to characterize adrenal uptake of cholesterol from HDL. In glands from untreated rats, uptake was found to be linear with time at 370 and greatly inhibited at 40 (Fig. 1) (Fig. 2) .
Effects of ACTH on Adrenal Mitochondrial Accumulation and Metabolism of HDL Cholesterol. Because the rate limiting step in adrenal steroidogenesis, conversion of cholesterol to pregnenolone, occurs in the mitochondria, uptake and metabolism of labeled cholesterol arising from extracellular HDL was examined in these organelles. Table 3 shows that more labeled cholesterol is transferred from extracellular HDL to in- Two pools of 10 adrenal pairs each, one from treated hypophysectomized rats, and another from untreated hypophysectomized rats were each incubated for 30 min at 370 in standard buffer containing [4-14C] cholesterol labeled HDL (850 jug of cholesterol/ ml, 208 cpm/gg of cholesterol) and AG (0.25 mg/ml). The pooled glands in each group were then washed, homogenized, and the mitochondria recovered as previously described (19) . Prior to isolation of the mitochondria, an aliquot of the total homogenate was used for determination of total gland radiolabeled cholesterol content. Protein and radiolabeled cholesterol content were determined on duplicate aliquots of isolated mitochondria from each group and the mean value is shown. Two groups of 10 adrenal pairs each (one group from ACTH treated and one from untreated hypophysectomized rats) were incubated for 1 hr in standard buffer containing AG (0.25 mg/ml) and [4-14C] cholesterol labeled HDL (850 ug of chblesterol./ml, 208 cpm/gg of cholesterol). Mitochondria from each pooled group of adrenal glands were isolated as previously described (19) . Duplicate aliquots from each group were incubated, not in the absence of AG, at both 370 and 40 for 30 min as previously described (19) . Each incubation mix containing mitochondria was extracted and pregnenolone separated by thin layer chromatography and counted as described in Materials and Methods. tracellular mitochondria by glands from ACTH treated hypophysectomized rats than by glands from untreated hypophysectomized rats. Furthermore, the percentage of the total labeled cholesterol accumulated by the gland which is transferred to the mitochondria is increased by ACTH treatment. Whereas ACTH treatment increases total adrenal gland uptake of labeled cholesterol from HDL 1.5 times (Table 1) , it increases mitochondrial uptake 2.75 times (Table 3) . Thus, ACTH treatment appears not only to increase adrenal cholesterol uptake but-also promotes delivery of accumulating cholesterol to the mitochondria.
It was of particular importance to determine if the labeled cholesterol accumulating within the mitochondria of adrenal glands incubated with cholesterol-labeled HDL could be used as substrate for conversion to pregnenolone. Mitochondria were therefore isolated and the inhibitor of pregnenolone formation, AG, removed as described earlier. Table 4 shows that labeled cholesterol transferred to the mitochondria could serve as substrate for conversion to pregnenolone. A greater amount of labeled pregnenolone was recovered from mitochondria incubated at 370 than at 40 for both the ACTH treated and untreated groups. This suggests that labeled cholesterol entering the adrenal from extracellular HDL can serve the physiologic function of providing steroidogenic substrate.
Effects of Added ApoA-I and ApoA-II on Adrenal Uptake of HDL Cholesterol. After we determined that ACTH stimulated adrenal transfer of labeled cholesterol from HDL, it was of interest to examine the action of the HDL apoproteins, apoA-I and apoA-II, on this process. The adrenal glands from intact untreated rats were individually incubated in media containing [4-14C] cholesterol labeled HDL at a concentration of 480 ,u/ml. The indicated protein (Fig. 3) , at a final concentration of 0.5 mg/ml, was added to one of each pair of glands while the remaining gland incubated in the absence of added protein served as the control. Both apoA-I and apoA-II markedly enhanced the adrenal accumulation of [4-'4C] cholesterol from HDL during the 30 min incubation period. Albumin and 'y-globulin were without effect (Fig. 3) .
DISCUSSION
Previous studies (1) (2) (3) (4) (Fig. 1) . The process was also found to saturate at an HDL cholesterol concentration of about 900 ,ig/ml (Fig. 2) . Although this is well above the circulating levels of HDL cholesterol in normal rats, levels of greater than 200 ,ug/ml were reported in genetically obese rats (5 In our studies, it was important to determine if the labeled cholesterol transferred from HDL to the adrenal gland had entered normal physiologic pathways. The fact that the cholesterol could not be removed by washing and remained associated with sedimentable fractions after homogenization of the tissue indicates that it had become incorporated into or become bound to the tissue. Furthermore, the labeled cholesterol associated with mitochondria from glands previously incubated with HDL could be converted to pregnenolone. Thus, the labeled cholesterol arising from HDL appeared to have become incorporated into the gland and to serve normal physiologic functions.
The mechanism by which labeled cholesterol from HDL enters the adrenal cell is not yet known. The fact that the process is lipoprotein specific, is markedly influenced by HDL apoproteins, responds to ACTH stimulation, and is unaffected by endogenous cholesterol pool size makes isotopic exchange alone a highly unlikely explanation. Although isotopic exchange may account for some movement of labeled HDL cholesterol into the adrenal, preliminary studies employing adrenal cortical tumor cells in culture indicate that net movement of cholesterol from HDL into adrenal cells does occur (unpublished results). Another possible mechanism is bulk phase or nonselective endocytosis, a nonsaturable process (21, 22) . The fact that adrenal uptake of HDL cholesterol is saturable and enhanced by ACTH while uptake from LDL is not makes this an unlikely explanation for the current observations. An additional mechanism by which cells accumulate extracellular macromolecules proceeds by saturable cell membrane binding, endocytosis, and lysosomal fusion (22) . Such a mechanism may account for the uptake of LDL by normal cultured human fibroblasts (23, 24) . Further studies are underway to determine if this accounts for adrenal uptake of HDL cholesterol. In any event, the process of cholesterol uptake in the adrenal shows very different specificity from that in cultured fibroblasts. HDL instead of LDL appears to be the preferred substrate in the adrenal. Because the HDL apoproteins, apoA-I and apoA-II, are water soluble in the delipidated state, we were able to examine their effects on adrenal cholesterol uptake from HDL. At less than saturating HDL concentrations, both apoproteins stimulate cholesterol transfer. The mechanism by which they produce this effect is not yet known but studies employing '25I-labeled-apoA-I showed a reversible hormonally sensitive binding site to be present in adrenal tissue (unpublished results).
Although the current studies show that HDL cholesterol enters the adrenal cell, they do not allow us to say if the whole HDL particle also enters. Bierman et al. (19) used lipoproteins labeled in both the apoprotein and lipid moieties and observed a disproportionate uptake of lipid relative to protein. Lipoprotein specific receptor mediated transmembrane movement specific for small-molecular-weight constituents of the serum lipoproteins, therefore, offers another alternative explanation for our observations. Further studies are underway to gain greater insight into the mechanism by which HDL cholesterol enters the adrenal cell.
